Nox

Quick links to important sections

Nox

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nox

Quick Facts

Property Description
Active ingredient Norfloxacin
Form Tablet (Oral), Ophthalmic Solution (Local)
Pharmacological class Fluoroquinolone Antibiotic
Common use Systemic and local bacterial infections
Origin Synthetic Compound
Legal Status Prescription-Only Medicine (Rx)

What is Nox: Composition and Core Identity

Nox is a medicinal product centered on the active ingredient Norfloxacin, which is a synthetic compound entirely manufactured chemically rather than derived from natural sources. The drug is classified as a Prescription-Only Medicine (Rx), a key differentiator indicating that its use requires direct medical supervision. Norfloxacin is considered a single-ingredient product, focusing its action solely on the properties of the primary substance. It is formulated for distinct uses: as an oral tablet for systemic treatment and as an ophthalmic solution for targeted local application, which determines whether the medicine treats the entire body or a specific external area.

Norfloxacin’s Pharmacological Classification and Type

Norfloxacin is definitively classified as a Fluoroquinolone antibiotic, a powerful group of broad-spectrum quinolone antibacterial agents engineered to combat a wide variety of microbial pathogens. This classification places it among modern chemotherapeutic agents distinguished by their enhanced activity against bacteria compared to older drug generations. The World Health Organization includes Norfloxacin on its Model List of Essential Medicines, which identifies it as a crucial therapeutic tool. This class exhibits effectiveness against many Gram-negative bacteria, confirming its utility in treating common microbial challenges, such as those found in uncomplicated urinary tract infections.

General Purpose of this Antibacterial Agent

The essential purpose of Nox is to provide bactericidal activity, meaning it actively kills bacterial pathogens that cause infection. As a broad-spectrum antibacterial agent, its function is to neutralize the root cause of the bacterial invasion by selectively disrupting the bacteria's vital genetic processes, preventing their replication and survival. This mechanism allows the drug to clear the microbial burden, enabling the resolution of the bacterial infection that would otherwise require targeted intervention.

Regulatory References

  1. WHO Model List of Essential Medicines (eEML) - Norfloxacin

What side effects are possible with Nox?

Possible Side Effects and Safety Information

The safety profile of Nox, which contains the fluoroquinolone antibiotic Norfloxacin, is formally documented by regulatory authorities (e.g., FDA, EMA) based on classified adverse reaction categories.


Adverse Reactions Scope

Adverse reactions are grouped by System-Organ Class (SOC) and incidence rate. Common effects (may affect up to 1 in 10 people) generally involve the Gastrointestinal disorders (e.g., Nausea) and Nervous system disorders (e.g., Headache and Dizziness). Uncommon effects (up to 1 in 100 people) include Skin and subcutaneous tissue disorders (e.g., Rash, Pruritus) and Psychiatric disorders (e.g., Depression, Insomnia).


Serious Adverse Reactions

The regulatory labels highlight serious adverse reactions that are classified as Rare or Very Rare, due to their potential for severe or long-lasting consequences. These primarily include Tendonitis and Tendon Rupture (especially the Achilles tendon) in the Musculoskeletal system, and potentially disabling and irreversible Peripheral Neuropathy in the Nervous system. Other documented serious effects include Psychotic reactions and the risk of exacerbating Myasthenia Gravis.


Safety Considerations and Limitations

Specific safety considerations are noted for certain populations. Older adults have a documented increased risk of tendon rupture. Use in pediatric patients is generally restricted due to the potential for joint damage. The medicine is formally contraindicated in persons with a history of hypersensitivity to any quinolone or a history of tendon disorders related to this drug class. Exposure notes state that serious adverse reactions may occur rapidly after treatment initiation.

Overdose and Emergency Response

Overdose and when to seek help

Overexposure to Norfloxacin requires immediate regulatory-mandated action. Documented clinical manifestations of an overdose include gastrointestinal disturbances such as vomiting, diarrhoea, and gastrointestinal haemorrhage. Additionally, central nervous system effects may occur, including dizziness, tinnitus, and convulsions.

A significant overdose carries the documented risk for severe systemic outcomes. These potential complications involve the liver and kidneys, specifically liver damage and the development of acute renal failure.

When to Seek Urgent Medical Help

Official regulatory guidance states that an individual must contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if the individual has not developed any symptoms. This immediate action is mandated due to the potential for delayed, life-threatening complications.

Management Measures

No specific antidote is known for Norfloxacin overexposure. Treatment is confined to symptomatic and supportive treatment. Procedural measures may include the administration of activated charcoal for a potentially toxic overdose, or gastric decontamination (such as gastric lavage) in cases of potentially life-threatening ingestion. The severity of overexposure is classified based on whether the ingestion is deemed potentially toxic or potentially life-threatening.

Therapeutic Uses of Nox

What Nox Treats: Main Uses and Benefits

The medication is applied in situations involving certain distressing symptoms caused by bacterial presence, offering supportive therapeutic benefit across distinct symptomatic domains. This is commonly used in contexts involving acute or disruptive symptom patterns, and its applications are relevant across several therapeutic areas.

Nox is commonly used across conditions presenting with acute episodes in the genitourinary tract, including cystitis, prostatitis, and recurrent urinary tract infections. It is also relevant for managing acute bacterial gastroenteritis, Traveler's diarrhea, and certain sexually transmitted infections. Furthermore, the ophthalmic solution is applied for local, targeted treatment of external eye infections.

By addressing the bacterial presence, the medication helps alleviate intense and disruptive symptom clusters, such as painful or frequent urination and severe watery diarrhea. This helps patients cope more steadily with symptom fluctuations.

“Applied in clinical settings that involve acute or unstable symptom patterns, the medication assists with maintaining functional stability.”


Quick Fact: Symptom Support

Quick Fact: Relief for Urinary Distress The medication is relevant for easing symptoms related to inflammatory or irritative states in the lower urinary tract, supporting patients during episodes of heightened discomfort.

Regulatory References

  1. NIH LiverTox overview of Norfloxacin

Eligibility and Restrictions for Use

The eligibility for using Nox (Norfloxacin) is strictly defined by regulatory authorities based on patient history, age, and specific health conditions. The medicine is primarily intended for use in the adult population.

Populations for Whom Use is Contraindicated

Category Official Regulatory Statement
Hypersensitivity/Allergy Contraindicated in persons with a history of hypersensitivity to Norfloxacin or any member of the quinolone class of antibiotics.
Specific Pre-existing Conditions Contraindicated in patients with a history of tendinitis or tendon rupture related to fluoroquinolone use, or those with known myasthenia gravis.

Age and Condition-Based Eligibility

Category Regulatory Status
Pediatric Population Use is not recommended; safety and effectiveness have not been established in children and adolescents.
Severe Renal Impairment Eligibility is conditional; patients with severe kidney impairment (creatinine clearance le 30 mL/min) require an alteration of the labeled dosage.
Pregnancy and Lactation Use during pregnancy is generally not recommended or advised only if the benefit outweighs the potential risk to the fetus. Some authorities advise discontinuing breastfeeding during treatment.

Eligibility-Related Restrictions

Use requires special caution in populations with a history of CNS disorders (such as epilepsy) or those with established risk factors for aortic aneurysm or dissection (such as Marfan syndrome or familial history).

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section details the officially documented interaction patterns for Norfloxacin (Nox) as presented in government regulatory documents.


Official Regulatory Interaction Profile

Classification Interacting Entity Regulatory Finding / Requirement
Contraindicated Combination Tizanidine Concomitant use is prohibited due to the risk of increased Tizanidine plasma concentrations.
Metabolic Mechanism CYP1A2 Substrates Norfloxacin inhibits CYP1A2, reducing the clearance of drugs like Theophylline, Caffeine, and Clozapine, and increasing their systemic exposure.
Pharmacodynamic Risk Oral Anticoagulants (e.g., Warfarin) May enhance the anticoagulant effect, requiring close monitoring of Prothrombin Time.
Absorption Interference Antacids, Sucralfate, Iron/Zinc Products Must be administered at least 2 hours apart from this medicine to prevent significantly reduced absorption.

Specific Interaction Cautions

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) carry a specific caution; co-administration may increase the official risk of Central Nervous System stimulation. Furthermore, the combination of this medicine with Corticosteroids is associated with an elevated risk of tendinitis and tendon rupture, a risk that is explicitly noted as being higher in elderly patients and individuals with renal impairment. The ingestion of milk or other dairy products should be separated from this medicine's administration to ensure adequate absorption.

Mechanism of Action

Molecular Blockade of Bacterial Genetic Management

Norfloxacin works by targeting two critical bacterial enzymes, DNA Gyrase and Topoisomerase IV, which are essential for controlling the coiling, separation, and repair of the bacterial genome. The drug binds directly to the enzyme-DNA complex, inhibiting their ability to seal the cleaved DNA strands. This highly specific action acts within the domain of bacterial genetic management to alter the function of these enzymes.


Mechanistic Cascade Resulting in Bactericidal Action

The stabilization of the DNA-enzyme intermediate triggers a molecular cascade, causing an uncontrolled accumulation of double-stranded DNA breaks throughout the bacterial cell. The genetic disruption prevents the cell from completing replication and segregation, resulting in the physiological action of bactericidal killing. The intensity of this effect operates on a concentration-dependent killing mechanism.


️ Constraints via Target Modification and Efflux

The mechanism of Norfloxacin is physiologically constrained by bacterial defense systems. Resistance occurs when pathogens genetically alter the drug's target enzymes (gyrA and parC/E mutations) or actively lower the effective drug concentration by overexpressing specialized efflux pumps that expel Norfloxacin from the cell. These mechanistic constraints define conditions where the drug's functional activity is reduced.

Dosage and Administration Information

Nox is administered via two distinct official routes: the 400 mg tablet is used for systemic treatment, while the 0.3% solution is approved for topical ocular application. For most systemic infections, the standard oral regimen is 400 mg taken every 12 hours. This twice-daily pattern ensures consistent drug levels, but it requires adherence to specific intake rules. The tablet must be swallowed with water and taken at least one hour before or two hours after any meal, milk, or dairy products, as consuming them too closely may hinder absorption.

The duration of treatment is standardized and depends on the specific infection being managed, ranging from a short course of three days for certain uncomplicated urinary tract infections up to 28 days for conditions like prostatitis. The full duration must be completed as prescribed. In cases of missed timing, official procedures state that the dose should be taken as soon as it is remembered, but patients must not double up the next dose to compensate.

Usage instructions are modified for specific patient populations. For individuals with significantly impaired kidney function (Creatinine Clearance le 30 mL/min/1.73 m^2), the systemic dose is typically reduced to 400 mg once daily. Conversely, no dosage adjustment is required for older adults whose renal function remains within normal limits. The safety and efficacy of the oral tablet are not established for pediatric use, meaning there are no official pediatric dosing guidelines.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nox

Evidence for Use in Treating Urinary Tract Infections (UTI)

Research has primarily focused on the use of Norfloxacin in uncomplicated Urinary Tract Infections (UTIs) and in preventing their recurrence, largely through short-term Randomized Controlled Trials (RCTs). Studies monitored microbiological eradication and clinical response (how symptoms were reported). Findings from regulatory reviews describe patterns related to short-term microbiological response in patients. The primary evidence is based on older trials, and the continued applicability of these findings is uncertain due to the documented increase in bacterial resistance to fluoroquinolones globally.

Evidence for Use in Preventing Spontaneous Bacterial Peritonitis (SBP)

Norfloxacin was evaluated in RCTs and systematic reviews for prophylactic strategies in high-risk patients with advanced liver cirrhosis (SBP prevention). Researchers examined the incidence of SBP episodes and monitored overall patient survival. Initial regulatory studies described patterns in SBP incidence when compared to control groups. However, some recent systematic reviews indicate the certainty remains low regarding long-term patient survival outcomes. The emergence of quinolone-resistant organisms is a key pattern observed in long-term prophylaxis studies.

Evidence for Use in Other Specific Acute Infections

Research has explored the application in acute episodes like bacterial gastroenteritis and Traveler's Diarrhea through short-term comparative trials. The outcomes studied related to symptom duration and microbiological measurements. The evidence supporting these specific indications is based primarily on older trials, where researchers worked in settings with a lower prevalence of modern antibiotic resistance. These older findings may not reflect current effectiveness patterns.

Long-Term Evidence and Follow-Up in Clinical Research

Research has explored the long-term use of Norfloxacin mainly for preventing recurrent infections. However, follow-up durations were limited, often extending only up to six to twelve months. Long-term effects are not fully established beyond the observation periods of the original trials, and data for long-term outcomes regarding functional well-being remain insufficient.

Research in Specific Patient Populations

Primary studies for Norfloxacin were conducted in broad adult populations, and the results apply only to the populations studied. Research has explored use in older adults (the geriatric population). However, the drug was not fully evaluated in children (pediatric populations), and limited information is available for pregnant or breastfeeding populations.

Key Studies & References NIH LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, Norfloxacin

Frequently Asked Questions (FAQ)

Common questions about Nox (FAQ)

Q: How quickly should I expect Nox to start working?

A: Studies on healthy volunteers indicate that the drug reaches its maximum concentration in the blood within approximately one to one and a half hours after an oral dose. This timeframe represents the concentration peak in the bloodstream, but it does not correspond directly to the onset of symptom improvement.

Q: Can Nox affect sleep?

A: Official documents list difficulty sleeping, known as Insomnia, as an uncommon adverse reaction associated with the drug. Drowsiness has also been reported in clinical studies. This is noted as part of the possible effects the medicine can have on the nervous system.

Q: Is it common to feel tired when taking Nox?

A: Official records state that both Fatigue and Weakness have been reported as side effects in clinical studies of the medicine. These effects may vary in how frequently they occur and how severe they are among different individuals.

Q: Does Nox interact with common over-the-counter supplements?

A: Official regulatory information specifies that Nox must be administered separately from certain mineral-containing products. This includes over-the-counter supplements that contain iron, zinc, magnesium, and calcium. Taking these substances too close to the medicine can significantly reduce how much of the drug the body absorbs.

Q: Can I stop using Nox suddenly?

A: Official instructions specify that the full duration of the prescribed treatment must be completed. This procedure is intended to support successful treatment outcomes and reduce the potential for the development of drug-resistant bacteria.

Q: What is the difference between Nox and a placebo in clinical trials?

A: In clinical trials, Nox contains the active drug Norfloxacin that is designed to work against bacteria. A placebo is a substance that looks exactly like the medicine but contains no active ingredient. Researchers use this comparison to determine the true effects of the active drug.

Q: How is the effectiveness of Nox measured in studies?

A: The effectiveness of the medicine in clinical research is primarily measured in two ways. Researchers track microbiological eradication (confirming the bacteria are killed or removed) and observe the clinical response (monitoring changes in a patient’s symptoms).

Q: Is it normal to feel a mild headache when first starting Nox?

A: Official documents list Headache as a common side effect, meaning it has been reported in up to 1 in 10 people in studies. This reaction may occur when a patient first begins taking the medication.

Q: Is Nox prescribed for conditions other than the main one listed?

A: Official documents describe a range of approved uses for the drug. These indications include certain types of uncomplicated urinary tract infections, infection of the prostate, uncomplicated gonorrhea, and specific types of gastroenteritis/Traveler's Diarrhea.

Q: How does Nox compare to other similar treatments I've heard about?

A: Official regulatory documents, such as the FDA and EMA labels, focus only on the established effects and safety profile of Nox itself. They do not contain any comparative information regarding how its effectiveness or side effects relate to other specific medicines.

Q: Can Nox cause changes in mood or behavior?

A: Official information lists Psychiatric disorders as an uncommon adverse reaction. This category includes reported changes such as Depression, Insomnia, Anxiety, and Psychotic reactions. Due to these possibilities, the medicine is noted to be used with caution in people who have a history of Central Nervous System disorders.

Q: What does it mean that Nox works on a specific pathway?

A: The 'pathway' refers to the specific, vital processes within the bacterial cell. Nox acts by blocking two specific bacterial enzymes—DNA Gyrase and Topoisomerase IV—which the bacteria require to manage their genetic material.

Q: Does Nox cause weight gain or loss?

A: Official adverse reaction reports indicate that isolated events of both weight gain and unusual weight loss have been reported. However, these effects are not generally listed among the medicine's common or frequent side effects.

Q: Are there any foods or drinks I need to avoid while using Nox?

A: To ensure proper absorption, the drug must be taken at least one hour before or two hours after consuming meals, milk, other dairy products, or calcium-fortified foods/juices. These substances must be separated from the medicine's administration to ensure adequate absorption.

Q: Does Nox affect blood pressure?

A: Animal studies have demonstrated that the drug may cause a transient reduction in blood pressure. However, the official human adverse reaction listing generally does not list a frequent effect on blood pressure in clinical use.

Q: Is Nox a controlled substance?

A: Nox is designated as a Prescription-Only Medicine (Rx) by regulatory authorities. It is not classified as a federally controlled substance in the US or an equivalent restricted schedule globally based on its regulatory status.

Q: Does Nox have an expiry date, and where can I find it?

A: Like all regulated medicines, the product has an expiry date printed on the packaging to ensure its stability and effectiveness. This date is required by regulatory agencies to be printed on the outer carton and the blister packaging of the medicine.

Q: How soon after starting Nox can I see the full benefit?

A: Studies suggest that steady-state concentrations (the point where drug levels remain consistent) may be attained after two days of the recommended twice-daily dosage. This indicates when the medicine is working at full, consistent strength in the body.

Q: Does Nox affect fertility?

A: There is limited information available regarding effects on human fertility. Animal studies, which are designed to detect possible risks, have revealed evidence of effects on the embryo, which is one reason use during pregnancy is advised only if the benefit is deemed to outweigh the potential risk.

Q: How is Nox eliminated from the body?

A: The drug is eliminated from the body primarily through the body’s waste disposal systems. It is excreted through both the kidneys (renal excretion) and in the feces (fecal excretion), with a mean elimination half-life of approximately three hours.

Q: Can people with liver disease use Nox?

A: Official documents note that use with caution is generally recommended. This is due to rare reports of liver injury associated with this drug class. Cases of severe liver injury have been reported, often occurring shortly after treatment begins.

Q: Does Nox interact with alcohol?

A: The drug’s regulatory documentation does not specifically list alcohol (ethanol) as a documented interaction that requires dose adjustment or prohibition.

Q: Is Nox available as a generic drug?

A: The active ingredient, Norfloxacin, is manufactured and recognized globally as an official generic substance by regulatory bodies. This indicates that generic versions of the medicine are available for prescription.

Q: How is 'off-label use' different from approved use for Nox?

A: The approved use (or 'on-label' use) is for the specific conditions that a regulatory agency, like the FDA, has formally reviewed and authorized the drug for. Off-label use means the drug is prescribed for a condition or dosage that is not included in that official, government-approved label.

Q: What is the role of the regulatory agency (like the FDA) in approving Nox?

A: Regulatory agencies are responsible for performing a comprehensive review of all the research evidence, including safety and efficacy data. They grant a formal Marketing Authorization or approval before the drug can be legally sold and prescribed to the public.

Q: Are there any known drug-disease interactions for Nox?

A: Yes, the official regulatory label includes specific contraindications and cautions for people with certain health conditions. These include a history of tendon disorders, Myasthenia Gravis, CNS disorders (e.g., epilepsy), and risk factors for aortic aneurysm or dissection.

Q: What kind of monitoring is typically required when using Nox?

A: Monitoring is specifically recommended for individuals taking oral anticoagulants (like Warfarin), where close observation of Prothrombin Time (a blood clotting measure) is required. Additionally, the label advises general patient observation for any signs of serious adverse reactions.

Q: Can Nox be crushed or split?

A: Some official patient information for Norfloxacin tablets specifies that they are film-coated but can be dispersed in water or crushed and mixed with liquid or soft food if necessary. These instructions must be aligned with the specific guidance provided in the product information for the tablet form.

Q: What happens if I accidentally take more Nox than prescribed?

A: In the event of a recent acute overdosage, official procedures specify that a patient should be carefully observed and given symptomatic and supportive treatment, including maintaining adequate hydration.

How should Nox be stored and disposed of?

Storage and Handling Requirements

Norfloxacin (Nox) must be stored under specific conditions to maintain stability. Both the tablets and the ophthalmic solution require storage at controlled room temperature, generally defined as 20 C to 25 C (68 F to 77 F), with excursions permitted as stated in the label. The medicine must be protected from excessive heat, moisture, and direct light and should not be frozen. To prevent degradation, tablets must be kept in a tightly closed container.

Stability and Child Safety

If using the ophthalmic solution, the product must be discarded one month after the bottle is opened. As with all medications, Norfloxacin must be kept out of the sight and reach of children.

Disposal

Unused or expired Norfloxacin should not be disposed of in household trash or down the drain. The medication should be returned to a local drug take-back program or disposed of according to the specific guidance provided by a healthcare professional or national regulatory authorities.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Nox found in:

A-Z Index: